Hashimoto's encephalitis; Adolescent; Adult; Child; Child, Preschool; Congresses as Topic; Encephalitis/diagnosis/therapy; Epilepsy/diagnosis/therapy; Epilepsy, Absence/diagnosis/therapy; Hashimoto Disease/diagnosis/therapy; Humans; Infant; Myoclonic Epilepsy, Juvenile/diagnosis/therapy; Rett Syndrome/diagnosis/therapy; Spasms, Infantile/diagnosis/therapy; Transition to Adult Care/trends; Treatment Outcome; Tuberous Sclerosis/diagnosis/therapy; Young Adult; Adolescence; Epilepsy; Outcome; Transition
Abstract :
[en] This is the second of three papers that summarize the second symposium on Transition in Epilepsies held in Paris in June 2016. This paper addresses the outcome for some particularly challenging childhood-onset epileptic disorders with the goal of recommending the best approach to transition. We have grouped these disorders in five categories with a few examples for each. The first group includes disorders presenting in childhood that may have late- or adult-onset epilepsy (metabolic and mitochondrial disorders). The second group includes disorders with changing problems in adulthood (tuberous sclerosis complex, Rett syndrome, Dravet syndrome, and autism). A third group includes epilepsies that change with age (Childhood Absence Epilepsy, Juvenile Myoclonic Epilepsy, West Syndrome, and Lennox-Gastaut syndrome). A fourth group consists of epilepsies that vary in symptoms and severity depending on the age of onset (autoimmune encephalitis, Rasmussen's syndrome). A fifth group has epilepsy from structural causes that are less likely to evolve in adulthood. Finally we have included a discussion about the risk of later adulthood cerebrovascular disease and dementia following childhood-onset epilepsy. A detailed knowledge of each of these disorders should assist the process of transition to be certain that attention is paid to the most important age-related symptoms and concerns.
Disciplines :
Psychiatry
Author, co-author :
Nabbout, R; Reference Centre for Rare Epilepsies, Pediatric Neurology, Necker-Enfants Malades University Hospital, APHP, University of Paris Descartes, Inserm U1129, Paris, France. Electronic address: rimanabbout@yahoo.com.
Andrade, D M; Department of Medicine, University of Toronto Adult Epilepsy Genetics Program, University of Toronto, Toronto Western Hospital, Toronto, Canada.
Bahi-Buisson, N; Embryology and Genetics of Congenital Malformations & Pediatric Neurology, Necker Enfants Malades University Hospital, Paris France.
Cross, H; UCL Institute of Child Health, London, UK.
Desquerre, I; Reference Centre for Rare Epilepsies, Pediatric Neurology, Necker-Enfants Malades University Hospital, APHP, University of Paris Descartes, Inserm U1129, Paris, France.
Dulac, O; Department of Pediatric Neuroscience, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy.
Granata, T; Department of Pediatric Neuroscience, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy.
Hirsch, E; Service de Neurologie, Hôpital de Hautepierre, Strasbourg, France.
Navarro, V; GH Pitie-Salpêtrière-Charles Foix, Epilepsy Unit and Department of Clinical Neurophysiology, Institut du Cerveau et de la Moelle, Paris, France.
Ouss, Lisa ; Reference Centre for Rare Epilepsies, Pediatric Neurology, Necker-Enfants Malades University Hospital, APHP, University of Paris Descartes, Inserm U1129, Paris, France.
Pearl, P L; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
Schmidt, D; Epilepsy Research Group, Free University of Berlin, Berlin, Germany.
Thiele, E; Director, Pediatric Epilepsy Program and Herscot Center for TSC, Massachusetts General Hospital, Boston, MA, United States.
Camfield, P R; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia, Canada.
Camfield, C S; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia, Canada.
[1] Camfield, P.R., Camfield, C.S., Busiah, K., Cohen, D., Pack, A., Nabbout, R., The transition from pediatric to adult care for youth with epilepsy: Basic biological, sociological, and psychological issues. Epilepsy Behav 69 (2017), 170–176.
[2] Nabbout, R., Camfield, C., Andrade, D., et al. Treatment issues for children with epilepsy transitioning to adult care. Epilepsy Behav 69 (2017), 153–160.
[3] Nabbout, R., Camfield, P., Transition of epilepsy care from children to adults. Epilepsia 55:Suppl. 3 (2014), 1–52.
[4] Saudubray, JM, van den Berghe, G, Walter, JH, (eds.), 5th edn Inborn Metabolic Diseases: Diagnosis and Treatment, Vol. XXVIII, 2012, Springer Medizin Verlag, Heidelberg, 64–67.
[5] Lapalme-Remis, S., Lewis, E.C., De Meulemeester, C., et al. Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood. Neurology 85 (2015), 861–865.
[6] Pearl, P.L., Wiwattanadittakul, N., Roullett, J.B., Gibson, K.M., Succinic semialdehyde dehydrogenase deficiency. Pagon, RA, Adam, MP, Ardinger, HH, Wallace, SE, Amemiya, A, Bean, LJH, Bird, TD, Fong, CT, Mefford, HC, Smith, RJH, Stephens, K, (eds.) GeneReviews® [Internet], 1993-2016, University of Washington, Seattle, Seattle (WA) Available from http://www.ncbi.nlm.nih.gov/books/NBK115333/ PubMed PMID: 23285490.
[7] El Sabbagh, S., Lebre, A.S., Bahi-Buisson, N., et al. Epileptic phenotypes in children with respiratory chain disorders. Epilepsia 51 (2010), 1225–1235.
[8] Grabhorn, E., Tsiakas, K., Herden, U., Fischer, L., Freisinger, P., Marquardt, T., et al. Long-term outcomes after liver transplantation for deoxyguanosine kinase deficiency: a single-center experience and a review of the literature. Liver Transpl 20 (2014), 464–472.
[9] Whittaker, R.G., Devine, H.E., Gorman, G.S., Schaefer, A.M., Horvath, R., Ng, Y., et al. Epilepsy in adults with mitochondrial disease: a cohort study. Ann Neurol 78 (2015), 949–957.
[10] http://www.tsalliance.org accessed July 10, 2016.
[11] Chu-Shore, C.J., Major, P., Camposano, S., Muzykewicz, D., Thiele, E.A., The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51 (2010), 1236–1241.
[16] Hagberg, B., Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 8 (2002), 61–65.
[17] Freilinger, M., Bebbington, A., Lanator, I., De Klerk, N., Dunkler, D., Seidl, R., et al. Survival with Rett syndrome: comparing Rett's original sample with data from the Australian Rett syndrome database. Dev Med Child Neurol 52 (2010), 962–965.
[18] Kirby, R.S., Lane, J.B., Childers, J., Skinner, S.A., Annese, F., Barrish, J.O., et al. Longevity in Rett syndrome: analysis of the North American database. J Pediatr 156 (2010), 135–138.
[19] Vignoli, A., Fabio, R.A., La Briola, F., Giannatiempo, S., Antonietti, A., Maggiolini, S., et al. Correlations between neurophysiological, behavioral, and cognitive function in Rett syndrome. Epilepsy Behav 17 (2010), 489–496.
[20] Halbach, N.S., Smeets, E.E., Schrander-Stumpel, C.T., van Schrojenstein Lantman de Valk, H.H., Maaskant, M.A., Curfs, L.M., Aging in people with specific genetic syndromes: Rett syndrome. Am J Med Genet A 146A (2008), 1925–1932.
[21] Williamson, S.L., Christodoulou, J., Rett syndrome: new clinical and molecular insights. Eur J Hum Genet 14 (2006), 896–903.
[22] Nissenkorn, A., Levy-Drummer, R.S., Epilepsy in Rett syndrome–lessons from the Rett networked database. Epilepsia 56 (2015), 569–576.
[23] Bahi-Buisson, N., Guellec, I., Nabbout, R., Guet, A., Nguyen, G., Dulac, O., et al. Parental view of epilepsy in Rett syndrome. Brain Dev 30 (2008), 126–130.
[24] Takayama, R., Fujiwara, T., Shigematsu, H., Imai, K., Takahashi, Y., Yamakawa, K., et al. Long-term course of Dravet syndrome: a study from an epilepsy center in Japan. Epilepsia 55 (2014), 528–538.
[26] Depienne, C., Trouillard, O., Saint-Martin, C., Gourfinkel-An, I., Bouteiller, D., Carpentier, W., et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 46 (2009), 183–191.
[27] Guzzetta, F., Cognitive and behavioral characteristics of children with Dravet syndrome: an overview. Epilepsia 52:Suppl. 2 (2011), 35–38.
[28] Nabbout, R., Chemaly, N., Chipaux, M., Barcia, G., Bouis, C., Dubouch, C., et al. Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy. Orphanet J Rare Dis, 8, 2013, 176.
[30] Chiron, C., Marchand, M.C., Tran, A., et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 356:9242 (2000), 1638–1642.
[31] Inoue, Y., Ohtsuka Y; STP-1 study group. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence. Epilepsy Res 108 (2014), 725–731.
[32] De Liso, P., Chemaly, N., Laschet, J., Barnerias, C., Hully, M., Leunen, D., et al. Patients with Dravet syndrome in the era of stiripentol: a French cohort cross-sectional study. Epilepsy Res 125 (2016), 42–46.
[33] Genton, P., Velizarova, R., Dravet, C., Dravet syndrome: the long-term outcome. Epilepsia 52:Suppl. 2 (2011), 44–49.
[34] Akiyama, M., Kobayashi, K., Yoshinaga, H., Ohtsuka, Y., A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 51 (2010), 1043–1052.
[35] Kuchenbuch, M., Chemaly, N., Chiron, C., Dulac, O., Nabbout, R., Transition and transfer from pediatric to adult health care in epilepsy: a families' survey on Dravet syndrome. Epilepsy Behav 29 (2013), 161–165.
[36] Fasano, A., Borlot, F., Lang, A.E., Andrade, D.M., Antecollis and levodopa-responsive parkinsonism are late features of Dravet syndrome. Neurology 82 (2014), 2250–2251.
[37] Gitiaux, C., Chemaly, N., Quijano-Roy, S., Barnerias, C., Desguerre, I., Hully, M., et al. Motor neuropathy contributes to crouching in patients with Dravet syndrome. Neurology 87 (2016), 277–281.
[38] Reilly, C., Atkinson, P., Das, K.B., Chin, R.F., Aylett, S.E., Burch, V., et al. Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics 133 (2014), e1586–e1593.
[39] Canitano, R., Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatry 16 (2007), 61–66.
[40] Amiet, C., Gourfinkel-An, I., Bouzamondo, A., Tordjman, S., Baulac, M., Lechat, P., et al. Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol Psychiatry 64 (2008), 577–582.
[41] Berg, A.T., Plioplys, S., Tuchman, R., Risk and correlates of autism spectrum disorder in children with epilepsy: a community-based study. J Child Neurol 26 (2011), 540–547.
[42] Davies, S., Heyman, I., Goodman, R., A population survey of mental health problems in children with epilepsy. Dev Med Child Neurol 45 (2003), 292–295.
[43] Saemundsen, E., Ludvigsson, P., Hilmarsdottir, I., Rafnsson, V., Autism spectrum disorders in children with seizures in the first year of le—a population-based study. Epilepsia 48 (2007), 1724–1730.
[44] Saemundsen, E., Ludvigsson, P., Rafnsson, V., Autism spectrum disorders in children with a history of infantile spasms: a population-based study. J Child Neurol 22 (2007), 1102–1107.
[45] Li, B.M., Liu, X.R., Yi, Y.H., Deng, Y.H., Su, T., Zou, X., et al. Autism in Dravet syndrome: prevalence, features, and relationship to the clinical characteristics of epilepsy and mental retardation. Epilepsy Behav 21 (2011), 291–295.
[46] Breuillard, D., Leunen, D., Chemaly, N., et al. Autism spectrum disorder phenotype and intellectual disability in females with epilepsy and PCDH-19 mutations. Epilepsy Behav 60 (2016), 75–80.
[47] Hallett, L., Foster, T., Liu, Z., Blieden, M., Valentim, J., Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin 27 (2011), 1571–1583.
[48] Tuchman, R., Alessandri, M., Cuccaro, M., Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment. Brain and Development 32 (2010), 719–730.
[49] Lew, A.R., Lewis, C., Lunn, J., et al. Social cognition in children with epilepsy in mainstream education. Dev Med Child Neurol 57 (2015), 53–59.
[50] Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics 125 (2010), e17–e23.
[51] Wirrell, E.C., Camfield, C.S., Camfield, P.R., Gordon, K.E., Dooley, J.M., Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 47 (1996), 912–918.
[52] Callenbach, P.M., Bouma, P.A., Geerts, A.T., Arts, W.F., Stroink, H., Peeters, E.A., Long-term outcome of childhood absence epilepsy: Dutch study of epilepsy in childhood. Epilepsy Res 83 (2009), 249–256.
[54] Wirrell, E.C., Grossardt, B.R., Wong-Kisiel, L.C., Nickels, K.C., Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980–2004: a population-based study. Epilepsy Res 95 (2011), 110–118.
[55] Bouma, P.A., Geerts, A.T., et al. Long-term outcome of childhood absence epilepsy: Dutch study of epilepsy in childhood. Epilepsy Res 83 (2009), 249–256.
[57] Wirrell, E., Camfield, C., Camfield, P., Dooley, J., Prognostic significance of failure of the initial anti-epileptic drug in children with absence epilepsy. Epilepsia 42 (2001), 760–767.
[58] Olsson, I., Campenhausen, G., Social adjustment in young adults with absence epilepsies. Epilepsia 34 (1993), 846–851.
[59] Wirrell, E.C., Camfield, C.S., Camfield, P.R., Dooley, J.M., Gordon, K.E., Smith, B., Long-term psychosocial outcome in typical absence epilepsy: sometimes a wolf in sheep's clothing. Arch Pediatr Adolesc Med 151 (1997), 152–158.
[60] Holtkamp, M., Senf, P., Kirschbaum, A., Janz, D., Psychosocial long-term outcome in juvenile myoclonic epilepsy. Epilepsia 55 (2014), 1732–1738.
[61] Schneider-von Podewils, F., Gasse, C., Geithner, J., Wang, Z.I., Bombach, P., Berneiser, J., et al. Clinical predictors of the long-term social outcome and quality of life in juvenile myoclonic epilepsy: 20–65 years of follow-up. Epilepsia 55 (2014), 322–330.
[62] Camfield, C.S., Camfield, P.R., Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 73 (2009), 1041–1045.
[63] Yagi, K., Evolution of Lennox-Gastaut syndrome: a long-term longitudinal study. Epilepsia 37:Suppl. 3 (1996), S48–S51.
[64] Archer, J.S., Warren, A.E., Jackson, G.D., Abbott, D.F., Conceptualizing Lennox-Gastaut syndrome as a secondary network epilepsy. Front Neurol 5 (2014), 225–230.
[65] Schropp, C., Staudt, M., Staudt, F., Bise, K., Obletter, N., Breit, A., et al. Delayed myelination in children with West syndrome: an MRI-study. Neuropediatrics 25 (1994), 116–120.
[66] Cusmai, R., Ricci, S., Pinard, J.M., Plouin, P., Fariello, G., Dulac, O., West syndrome due to perinatal insults. Epilepsia 34 (1993), 738–742.
[67] Aznar Laín, G., Dellatolas, G., Eisermann, M., Children often present with infantile spasms after herpetic encephalitis. Epilepsia 54 (2013), 1571–1576.
[68] Kasasbeh, A.S., Gurnett, C.A., Smyth, M.D., Palliative epilepsy surgery in Aicardi syndrome: a case series and review of literature. Childs Nerv Syst 30 (2014), 497–503.
[69] Gataullina, S., Lemaire, E., Wendling, F., et al. Epilepsy in young Tsc1(±) mice exhibits age-dependent expression that mimics that of human tuberous sclerosis complex. Epilepsia 57 (2016), 648–659.
[70] Honnorat, J., Didelot, A., Karantoni, E., Ville, D., Ducray, F., Lambert, L., et al. Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer. Neurology 80 (2013), 2226–2232.
[71] Malter, M.P., Helmstaedter, C., Urbach, H., Vincent, A., Bien, C.G., Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67 (2010), 470–478.
[72] Dalmau, J., Tüzün, E., Wu, H.Y., Masjuan, J., Rossi, J.E., Voloschin, A., et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61 (2007), 25–36.
[73] Titulaer, M.J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12 (2013), 157–165.
[74] Borusiak, P., Bettendorf, U., Wiegand, G., Bast, T., Kluger, G., Philippi, H., et al. Autoantibodies to neuronal antigens in children with focal epilepsy and no prima facie signs of encephalitis. Eur J Pediatr Neurol 20 (2016), 573–579.
[75] Navarro, V., Kas, A., Apartis, E., Chami, L., Rogemond, V., Levy, P., et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 139 (2016), 1079–1093.
[78] Bien, C.G., Granata, T., Antozzi, C., Cross, J.H., Dulac, O., Kurthen, M., et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 128 (2005), 454–471.
[79] Bulteau, C., Grosmaitre, C., Save-Pédebos, J., Leunen, D., Delalande, O., Dorfmüller, G., et al. Language recovery after left hemispherotomy for Rasmussen encephalitis. Epilepsy Behav 53 (2015), 51–57.
[80] Thiele, E.A., Granata, T., Matricardi, S., Chugani, H.T., Transition into adulthood: tuberous sclerosis complex, Sturge-Weber syndrome, and Rasmussen encephalitis. Epilepsia 55:Suppl. 3 (2014), S 29–S 33.
[81] Villani, F., Pincherle, A., Antozzi, C., et al. Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases. Epilepsia 47:supplement 5 (2006), s41–s46.
[82] Jaillon-Riviere, V., Dupont, S., Bertran, F., De La Sayette, V., Beuvon, F., Baulac, M., et al. Late onset Rasmussen's syndrome: clinical and therapeutic characteristics. Rev Neurol 163 (2007), 573–580.
[83] Deleo, F., Matricardi, S., Didato, G., Pappalardo, I., Villani, F., The dilemma of adult-onset Rasmussen encephalitis clinical assessment: proposal for a new bedside tool to evaluate disease progression. Epilepsy Behav 46 (2015), 249–251.
[84] Fauser, S., Huppertz, H.J., Bast, T., et al. Clinical characteristics in focal cortical dysplasia: a retrospective evaluaiton in a series of 120 patients. Brain 129 (2006), 1907–1916.
[85] Wirrell, E., Wong-Kisiel, L.C., Nickels, K.C., Seizure outcome after AED failure in pediatric focal epilepsy: impaact of underlying etiology. Epilepsy Behav 34 (2014), 20–24.
[86] Reinholdson, J., Olsson, I., Edelvik, A., Hallböök, T., Lundgren, J., Rydenhag, B., et al. Long-term followup after epilepsy surgery in infancy and early childhood- a prospective population based observational study. Seizure 2015:30 (2015), 83–89.
[87] D'Argenzio, L., Colonnelli, M.C., Harrison, S., Jacques, T.S., Harkness, W., Scott, R.C., et al. Seizure outcome after extratemporal epilepsy surgery in childhood. Dev Med Child Neurol, 2012, 995–1000.
[88] Ramantani, G., Kadish, N.E., Strobl, K., Brandt, A., Stathi, A., Mayer, H., et al. Seizure and cognitive outcomes of epilepsy surgery in infancy and early childhood. Eur J Paediatr Neurol, 17(498), 2013.
[89] Moosa, A.N., Jehi, L., Marashly, A., Cosmo, G., Lachhwani, D., Wyllie, E., et al. Long-term functional outcomes and their predictors after hemispherectomy in 115 children. Epilepsia 54 (2013), 1771–1779.
[90] Skirrow, C., Cross, J.H., Cormack, F., Harkness, W., Vargha-Khadem, F., Baldeweg, T., Long-term outcome after temporal lobe surgery in childhood; intellectual gains are correlated with brain volume changes. Neurology 76 (2001), 1330–1337.
[91] Skirrow, C., Cross, J.H., Harrison, S., Cormack, F., Harkness, W., Coleman, R., et al. Temporal lobe surgery in childhood and neuroanatomical predictors of long term declarative memory outcome. Brain 138 (2015), 80–93.
[92] Helmstaedter, C., Elger, C.E., Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease. Brain 132 (2009), 2822–2830.
[93] Davies, S., Heyman, I., Goodman, R., A population survey of mental health problems in children with epilepsy. Dev Med Child Neurol 45 (2003), 292–295.
[94] McLellan, A., Davies, S., Heyman, I., Harding, B., Harkness, W., Taylor, D., et al. Psychopathology in children with epilepsy before and after temporal lobe resection. Dev Med Child Neurol 47 (2005), 666–672.
[95] Colonnelli, M.C., Cross, J.H., Davies, S., D'Argenzio, L., Scott, R.C., Pickles, A., et al. Psychopathology in children before and after surgery for extratemporal epilepsy. Dev Med Child Neurol 54 (2012), 521–526.
[96] Puka, K., Smith, M.L., Long-term outcome of behavior problems after epilepsy surgery in childhood. J Neurol 263 (2016), 991–1000.
[97] Baca, C.B., Vickrey, B.G., Caplan, R., Vasser, S.D., Berg, A.T., Psychiatric and medical comorbidity and quality of life outcomes in childhood-onset epilepsy. Pediatrics 128 (2011), e1532–e1543.
[98] Jalava, M., Sillanpaa, M., Camfield, C., Camfield, P., Social adjustment and competance 35 years after onset of childhood epilepsy: a prospective controlled study. Epilepsia 38 (1997), 708–715.
[99] Skirrow, C., Baldeweg, T., Educational and employment outcomes following epilepsy surgery in childhood. Malmgren, K., Baxendale, S.A., Cross, J.H., (eds.) Long term outcomes of epilepsy surgery in adults and children, 2015, Springer, New York, 151–164.
[101] Toure, K., Coume, M., Ndiaye, M., Zunzunegui, M.V., Bacher, Y., Diop, A.G., et al. Risk factors for dementia in a Senegalese elderly population aged 65 years and over. Dement Geriatr Cogn Dis Extra 2 (2012), 160–168.
[102] Chin, J., Scharfman, H.E., Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms. Epilepsy Behav 26 (2013), 343–351.
[103] Costa, C., Parnetti, L., D'Amelio, M., Tozzi, A., Tantucci, M., Romigi, A., et al. Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?. Neurobiol Aging 48 (2016), 161–171.
[104] Sima, X., Xu, J., Li, J., Zhong, W., You, C., Expression of β-amyloid precursor protein in refractory epilepsy. Mol Med Rep 9 (2014), 1242–1248.
[105] Sillanpää, M., Anttinen, A., Rinne, J.O., Joutsa, J., Sonninen, P., Erkinjuntti, M., et al. Childhood-onset epilepsy five decades later. A prospective population-based study. Epilepsia 56 (2015), 1774–1783.
[106] Sillanpää, M., Karrasch, M., Rinne, J., et al. Later-life cognition and brain structure in persons with childhood onset epilepsy. American Epilepsy Society Annual Meeting, poster. San Diego 2012, Abstract Epilepsia, 2012.
[107] Anttinen, A., Joutsa, J., Rinne, J.O., et al. Increased amyloid burden in childhood-onset epilepsy five decades later—A prospective case-control study. Poster, XIII Turku PET symposium in conjunction with the symposia of Nordic Association for Clinical Physics (NACP), and Scandinavian Society of Clinical Physiology and Nuclear Medicine (SSCPNM), Turku, 24–27 May, 2014.
[108] Anttinen, A., Joutsa, J., Rinne, J.O., Karrasch, M., Tiitta, P., Sonninen, P., Erkinjuntti, M., Shinnar, S., Hermann, B., Sillanpää, M., Increased amyloid burden in childhood-onset epilepsy five decades later—A prospective case-control study. Poster, XIII Turku PET symposium in conjunction with the symposia of Nordic Association for Clinical Physics (NACP), and Scandinavian Society of Clinical Physiology and Nuclear Medicine (SSCPNM), Turku, 24-27 May, 2014.
